Related Experiment Videos
Randomized comparison of intravenous versus intracoronary streptokinase for myocardial infarction
Insights
Intravenous thrombolytic therapy shows comparable efficacy to intracoronary streptokinase for recanalization. Early i.v. administration in emergency settings may improve myocardial preservation by restoring blood flow sooner.
Area of Science:
- Cardiology
- Pharmacology
- Emergency Medicine
Background:
- The comparative efficacy of intravenous (i.v.) versus intracoronary (i.c.) thrombolytic therapy remains unclear.
- Streptokinase (STK) is a key thrombolytic agent used in managing acute cardiovascular events.
Purpose of the Study:
- To compare the recanalization rates and time to reperfusion between i.v. and i.c. administration of streptokinase.
- To identify factors influencing successful thrombolysis and assess bleeding complications.
Main Methods:
- A randomized trial involving 28 patients undergoing angiography.
- Administration of streptokinase via both i.v. and i.c. routes.
- Assessment of recanalization, time to reopening, euglobulin lysis times, fibrinogen levels, and bleeding complications.
Main Results:
- Recanalization rates were 73% for i.c. STK and 62% for i.v. STK (not statistically significant).
- Time to reopening was shorter with i.c. STK (28 minutes) compared to i.v. STK (39 minutes).
- Successful recanalization correlated with shorter euglobulin lysis times and lower fibrinogen levels. Bleeding complications were linked to post-thrombolysis heparinization.
Conclusions:
- Intravenous streptokinase demonstrates similar recanalization potential to the intracoronary route.
- Early i.v. STK administration in emergency departments may offer benefits for myocardial preservation by enabling faster reperfusion.
Abstract:
The efficacy of intravenous (i.v.) thrombolytic therapy has not been firmly established in comparison with the intracoronary (i.c.) route of administration. In a randomized trial of 28 patients who underwent angiography before and during i.v. and i.c. administration of streptokinase (STK), recanalization was achieved in 73% of patients who received the drug by the i.c. route, compared with 62% of patients who received the drug by the i.v. route (difference not significant). Reopening took 28 minutes for i.c. STK and 39 minutes for i.v. STK. Patients in whom recanalization was successful using either route of administration had shorter euglobulin lysis times and lower fibrinogen levels than did patients in whom it was not successful (p less than 0.05). Bleeding complications were closely correlated with heparinization after thrombolysis rather than with STK itself. These results in a limited patient series suggest that early administration of i.v. STK in the emergency department may yield recanalization rates similar to those for the i.c. route and may benefit myocardial preservation by restoring flow much earlier.